VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 0934757
Sex: M
Age:
State: AL

Vax Date: 07/01/2020
Onset Date: 07/02/2020
Rec V Date: 01/11/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Pt received 1st dose on 7/1/20 at Walgreens pharmacy-received 2nd dose on 8/31/20 MSO at WAG. Pt reported complete arm muscle weakness, numbness - decreased range of motion. After 2nd dose pt could hardly move arm

Other Meds:

Current Illness: unknown - none reported

ID: 0934758
Sex: M
Age: 61
State: TX

Vax Date: 01/04/2021
Onset Date: 01/08/2021
Rec V Date: 01/11/2021
Hospital:

Lab Data: CT HEAD CTA

Allergies: NKDA

Symptoms: PATIENT PRESENTED TO ER ON 1/8/21 @ 6AM WITH STROKE SYMPTOMS INCLUDING (R) SIDE WEAKNESS

Other Meds: COREG, DIOVAN HCT, LASix, CiALis, MOBiC, ASA

Current Illness:

ID: 0934869
Sex: F
Age: 83
State: MI

Vax Date: 01/05/2021
Onset Date: 01/06/2021
Rec V Date: 01/11/2021
Hospital: Y

Lab Data: Please see attached documentation

Allergies: none noted

Symptoms: Patient had a rash prior to COVID vaccine. Prednisone 10mg started on 1/5/21 (only one dose administered) 1/6/21, 1am - Rash worsened with increase redness, warmth and extending of body surface, Temp 100.4, 1/6/21, 1:20am Benadryl 25mg administered, (Keflex was ordered at this time, however never administered). 1/6/21, 3am rash improved, temp 99.1 1/6/21, 6:50am Right facial droop and right sided weakness, sent to ER 1/6/21 transferred to hospital, continues to be hospitalized 1/11/2021

Other Meds: Prednisone 10mg, Donepezil HCL 10mg, Breo Ellipta inhaler, Spiriva Inhaler, Plavix

Current Illness: Rash, Non hemorrhagic CVA in 2009, Alzheimer's dementia, COPD, HLD, CKD, Allergic Rhinitis

ID: 0934877
Sex: F
Age:
State: PR

Vax Date: 12/17/2020
Onset Date: 12/24/2020
Rec V Date: 01/11/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Patient expressed: Pain in the left side of the face and migraine on 25Dec2020, and came to emergency room where apparently they diagnosed facial paralysis; Patient expressed: Pain in the left side of the face and migraine on 25Dec2020, and came to emergency room where apparently they diagnosed facial paralysis; This is a spontaneous report from a contactable nurse. A 42-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number EK5730) intramuscular, on 17Dec2020 04:15, single dose arm left for COVID-19 immunization. Relevant medical history included hypothyroidism, hypertension, hyperlipidemia, obesity, and penicillin allergy. Concomitant medications included levothyroxine sodium (SYNTHROID), butalbital, caffeine, paracetamol (FIORICET 50-40- 325mg), dexamethasone 4mg Inj., diclofenac (VOLTAREN 1% Gel), Magnesium, valsartan (VASOFLEX) (pending confirmation), cyanocobalamin (VITAMIN B12), losartan potassium. The patient was not pregnant and did not received any vaccine in four weeks. The patient previously took cephalosporin and experienced allergy. On 24Dec2020, the patient experienced pain left side of the face and migraine, and came to emergency room where apparently they diagnosed facial paralysis. The events resulted in emergency room visit/ urgent care where the patient was administered dexamethasone 4mg Inj, Medrol dose pack, Vit B12 500mcg, and Fioricet 50-325-40. Facility where the most recent COVID-19 vaccine was administered was in the doctor's office/urgent care. It was unknown if the patient was diagnosed with COVID-19 prior or since the vaccination. The events were assessed by the nurse as non-serious. Outcome of the events was recovering at the time of the report.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation between vaccination and onset of events. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.

Other Meds: SYNTHROID; FIORICET; ; VOLTAREN [DICLOFENAC]; ; VITAMIN B12 [CYANOCOBALAMIN]; ; VASOFLEX [VALSARTAN]

Current Illness:

ID: 0934885
Sex: F
Age: 49
State: AZ

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 01/11/2021
Hospital:

Lab Data:

Allergies: Promethazine- hives

Symptoms: Head ache started at 10:20am took Tylenol. At 12:15 i still have a headache. If head ache continues i will take more medications.

Other Meds: Topiramate 25mg 1 tablet am and 2 tablets pm for migraine prevention. Wixela inhaler i puff bid-for asthma Women?s one a day multi-vitamin Vitamin C Zinc

Current Illness: None

ID: 0934886
Sex: F
Age: 29
State: CA

Vax Date: 12/21/2020
Onset Date: 12/21/2020
Rec V Date: 01/11/2021
Hospital:

Lab Data:

Allergies: Sulfa

Symptoms: Headache

Other Meds:

Current Illness:

ID: 0934887
Sex: F
Age: 4
State: KY

Vax Date: 11/19/2020
Onset Date: 11/19/2020
Rec V Date: 01/11/2021
Hospital:

Lab Data:

Allergies:

Symptoms: patient did not have any type of reaction; freezer went out of range after being checked on 11/19/2020; This spontaneous report was received from a nurse and refers to a 4 year old female patient. There was no information about the patient's concomitant therapies or medical history provided. The patient's concurrent condition included congenital metatarsus adductus (reported as Q66.22). On 19-NOV-2020, the patient was vaccinated with improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA)(PROQUAD) (lot # T013540 and expiration date 17-OCT-2021) subcutaneously in the left thigh (LT) and diphtheria toxoid, pertussis acellular 5-component vaccine, poliovirus vaccine inactivated (mrc-5), tetanus toxoid (QUADRACEL) (lot # C5656AA and expiration date 13-AUG-2021 ) intramuscularly in the right thigh (RT) for prophylaxis. It was reported, that on that day the freezer went out of range and wasn't checked again until the afternoon of 20-NOV-2020. The manufacturer was notified and all vaccines were labeled with an excursion sticker. The patient's mother was notified of the event and she was understanding. The patient did not have any type of reaction. A data logger was used to capture that temperature excursion, but no further details regarding the temperatures were available.; Sender's Comments: US-009507513-2011USA013282:

Other Meds:

Current Illness: Metatarsus adductus; Prophylaxis

ID: 0934888
Sex: F
Age: 48
State: IN

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 01/11/2021
Hospital:

Lab Data: None

Allergies: None

Symptoms: 24 hours of chills, myalgia, headache, fatigue. Max temp 99.6

Other Meds: None

Current Illness: None

ID: 0934889
Sex: F
Age: 93
State: LA

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/11/2021
Hospital: Y

Lab Data:

Allergies: chlordiazepoxide [From Librium] ciprofloxacin [From Cipro] codeine diazepam meperidine morphine Nitrofuran Analogues ondansetron [From Zofran] oxycodone Penicillins pentazocine [From Talwin] propoxyphene [From Darvon] Sulfa (Sulfonamide Antibiotics)

Symptoms: HPI narrative: Patient was fine until 2 days ago. Patient does have chronic dementia but got Covid vaccine 11:00 2 days ago and that night seem to be confused and not able to walk since then. Patient poor appetite since yesterday. Patient had diarrhea 3 x 2 days ago. No vomiting no fever no cough does not appear to be short of breath. Patient also with left hip pain for few days with no injury.All history obtained from caretaker at bedside.

Other Meds: citalopram 20 mg PO DAILY clonazepam 0.5 mg PO DAILY lisinopril 10 MG PO DAILY loratadine 10 mg PO DAILY magnesium oxide 400 MG PO BID memantine 5 MG PO BID metoprolol tartrate 25 MG PO BID pantoprazole [Protonix] 40 MG PO DAILY warfarin 4

Current Illness:

ID: 0934890
Sex: F
Age: 23
State: MT

Vax Date: 01/07/2021
Onset Date: 01/11/2021
Rec V Date: 01/11/2021
Hospital:

Lab Data:

Allergies:

Symptoms: body aches, congestion

Other Meds:

Current Illness:

ID: 0934891
Sex: F
Age:
State: NV

Vax Date: 12/30/2020
Onset Date: 12/31/2020
Rec V Date: 01/11/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Started as a red raised rash under my arms and my waistline; rash turned to hot to touch; raised red large hives all over my body including my face/head; numbness to my hands/feet/chest area; the SOB started; This is a spontaneous report from a contactable nurse, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EU9231), via an unspecified route of administration in the left arm on 30Dec2020 at 08:30 as a single dose for COVID-19 immunization. Medical history included hypothyroidism and chronic low back pain. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), baclofen (MANUFACTURER UNKNOWN), and etodolac (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took miconazole nitrate (MONISTAT) on unknown dates for an unknown indication and experienced drug allergy. On 31Dec2020 at 10:00, the patient started with a red raised rash under her arms and waistline and as the day progressed the rash turned hot to touch with raised red large hives all over her body including her face/head. By 23:00 on 31Dec2020, the patient had already taken 3 doses of diphenhydramine (BENADRYL) which was not effective. Then, later on 31Dec2020, shortness of breath started with numbness in the hands/feet/chest area. Her daughter took her to the emergency room. She was started on intravenous diphenhydramine, dexamethasone, and famotidine (PEPCID). The medications took time to work but they did resolve her shortness of breath and the hives subsided to mild redness. She was sent home and given the following medications to take: diphenhydramine 50 mg every 4 hours, methylprednisolone (MEDROL DOSE PAK), cetirizine (ZYRTEC) daily, and famotidine (PEPCID) daily. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the red rash, rash was hot to touch, shortness of breath, and numbness, were reported as recovered with lasting effects; while that of the hives was recovering as they still flared up if she did not take the medications every 4 hours. The reporter assessed all the events as non-serious.; Sender's Comments: The reported shortness of breath together with red rash was probably related to the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE together with rash was probably related to the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), due to temporal relationship and clinical course. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory authorities, Ethics committees and Investigators, as appropriate.

Other Meds: ; ;

Current Illness:

ID: 0934892
Sex: F
Age: 30
State:

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/11/2021
Hospital:

Lab Data:

Allergies:

Symptoms: fever of 100.9, swollen lymph nodes, body aches, joint pain

Other Meds:

Current Illness:

ID: 0934893
Sex: F
Age:
State: PA

Vax Date: 12/20/2020
Onset Date: 01/01/2021
Rec V Date: 01/11/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Rectal bleeding; Stomach ache; Diarrhea; sick; This is a spontaneous report from a contactable consumer (patient) from a Pfizer sponsored program Pfizer First Connect. A 41-year-old female patient received the first dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EK5730 and Expiration Date: 31Mar2021), via an unspecified route of administration in the right arm on 20Dec2020 at a single dose for COVID-19 immunization. The patient's medical history was reported as none. There were no concomitant medications. On 01Jan2021, the patient experienced: rectal bleeding, stomachache, diarrhea, sick; all assessed as medically significant. The clinical course was reported as follows: The patient received the first dose of the COVID-19 vaccine on 20Dec2020; as she was at high risk due to working with COVID patients in the hospital. The patient became sick on 01Jan2021. The patient experienced a stomach-ache, diarrhea, and rectal bleeding. When these events occurred, the patient went to the emergency room (ER). A doctor there prescribed the patient the antibiotics metronidazole 500 mg and cefdinir 300 mg. The patient was also scheduled to follow up with a gastrointestinal (GI) doctor. The patient called asking if she should get the second dose since she was taking antibiotics. The patient was scheduled for the second dose on 08Jan2020.The patient reported she had improved. The symptoms, at the time of the report, were not that bad. Therapeutic measures were taken as a result of rectal bleeding, stomachache, diarrhea, and sick. The clinical outcome of the events was recovering.

Other Meds:

Current Illness:

ID: 0934894
Sex: M
Age: 46
State: MI

Vax Date: 01/11/2020
Onset Date: 01/11/2020
Rec V Date: 01/11/2021
Hospital:

Lab Data: NONE

Allergies: NO

Symptoms: HEAVY WARMTH FEELING IN EXTREAMITIES

Other Meds: NO

Current Illness: NO

ID: 0934895
Sex: F
Age:
State: MI

Vax Date: 12/01/2020
Onset Date: 12/31/2020
Rec V Date: 01/11/2021
Hospital:

Lab Data: Test Date: 20201231; Test Name: blood pressure; Result Unstructured Data: Test Result: increased; Comments: increased BP, all started 2 days after receiving the vaccine; Test Date: 20210101; Test Name: blood pressure; Result Unstructured Data: Test Result:170/92; Comments: blood pressure was up; it was up and down; Test Name: weight; Result Unstructured Data: Test Result:150-155 lbs; Test Date: 20201209; Test Name: white count; Result Unstructured Data: Test Result: went down

Allergies:

Symptoms: Numbness lips,mouth; Was feeling bad; leg numbness/numbness in head, face; pain in head; increased BP; blood pressure was up and down; This is a spontaneous report from a contactable consumer (patient). A 55-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL0140) via an unspecified route of administration in left arm on 29Dec2020 6 am at single dose for covid-19 immunisation. Co-suspected drug amoxicillin;clavulanic acid (AUGMENTIN, Batch/lot number: KN4291, Expiry Date: Mar2022) by mouth from Dec2020 to 28Dec2020 at 875mg, 1 tablet twice daily for pain or infection; MOXIFLOXACIN HYDROCHLORIDE (AVELOX, strength:400mg) by mouth from 29Dec2020 and ongoing at 400mg, 1 tablet once daily for infection; fluconazole (DIFLUCAN, strength:200mg) orally (by mouth) from unknown date and ongoing at 200mg, 1 tablet once daily for Infection.The patient's medical history was reported as ongoing high blood pressure, ongoing pains in her fingers and toes and they thought she had an infection from 02Dec2020, white count went down on 09Dec2020, ongoing pain was up and down. No other vaccines given at that time and none given 4 weeks prior. Had a Flu shot back in Oct2020, but no problems. None diagnosed allergies and family medical history relevant to adverse event. The concomitant medications included unspecified blood pressure medication by mouth daily for high blood pressure. She had also started 2 antibiotics around the same time that she received the vaccine. No further details provided Was on antibiotics at the time she was given the Pfizer COVID-19 vaccine. Patient experienced increased BP/ high blood pressure, pain in head, and leg numbness; all started 2 days (on 31Dec2020) after receiving the vaccine and persisted for 48 hours. First her blood pressure was up and they had to get it stable and had numbness in her head, face, and mouth for 48 hours. Her blood pressure was up and down and she has history of blood pressure and takes medicine. Was taken off work for a few hours and went to the emergency department on Fri night about 2am. Her blood pressure was 170/92 on 01Jan2021. Not sure if this was related to the vaccine, but the numbness in her head started from her upper neck to face to the right side of her check and she also had leg numbness. Wanting to know if this was related because she was worried about getting the second dose. Had a hard time for 48 hours. Weight was between 150-155 pounds. Stated everything improved after 48 hours. Her lip was also just a little bit numb, but it is feeling better. Patient was feeling bad from 01Jan2021, all Fri and Sat and much better by Sun. Events of increased BP/ blood pressure up and down, leg numbness, numbness in lips, head, face, mouth with emergency room visiting. Wanted to know if she should have the second dose. The action taken in response to Augmentin was permanently discontinued on 28Dec2020, for Avelox and Diflucan was dose not changed. The outcome of events was recovering.

Other Meds: AUGMENTINE [AMOXICILLIN;CLAVULANIC ACID]; AVELOX; Diflucan

Current Illness: Blood pressure high; Infection; Pain; Pain in fingers; Pain in toe

ID: 0934896
Sex: F
Age:
State: TX

Vax Date: 12/19/2020
Onset Date: 12/19/2020
Rec V Date: 01/11/2021
Hospital:

Lab Data:

Allergies:

Symptoms: eventually inability to move arm; pain; joint pain; tenderness at injection site; loss of strength; This is a spontaneous report from a contactable nurse. A 36-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/lot number: EJ1685) intramuscular at arm left, on 19Dec2020 06:45 at single dose for covid-19 immunisation. Medical history included ongoing acne. Patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included isotretinoin (ACCUTANE). On 19Dec2020 11:30, approximate 5 hours after vaccine, the patient experienced pain, joint pain and tenderness at injection site, progressively loss of strength and eventually inability to move arm. Since the vaccination, the patient hasn't been tested for COVID-19. The outcome of events was recovered.; Sender's Comments: Based on the compatible temporal association, the vaccination with BNT162B2 might play a contributory role in triggering the onset of the reported events. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds: ACCUTANE

Current Illness: Acne

ID: 0934897
Sex: F
Age: 51
State: PA

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 01/11/2021
Hospital:

Lab Data:

Allergies: Sulfa, Aspirin, IVP Dye, Shellfish, Beestings

Symptoms: Dizzy, Headache, unsteady on feet, chest feels heavy, nauseated

Other Meds: Trulicity, Metformin, Chlorothiazide

Current Illness:

ID: 0934898
Sex: F
Age:
State: TX

Vax Date: 12/28/2020
Onset Date:
Rec V Date: 01/11/2021
Hospital:

Lab Data: Test Name: test; Result Unstructured Data: Test Result:positive for blood in her stool; Comments: following a test at her doctor's she is positive for blood in her stool

Allergies:

Symptoms: she is positive for blood in her stool; left hip/back/kidney pain; left hip/back/kidney pain; left hip/back/kidney pain; This is a spontaneous report from a contactable consumer reporting for herself. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number and expiration date unknown) via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the vaccine on 28Dec2020 (reported on 05Jan2021 as 'a week ago Monday'). After getting the vaccine (2-3 days after getting the vaccine) she started to have some events happen that she was not sure were side effects from the vaccine. She mentioned she started to experience blood in her stool - following a test at her doctor's she was positive for blood in her stool. Also, the left side of her lower back and hip started hurting. She was experiencing left hip/back/kidney pain, as reported. She took hydrochlorothiazide. The outcome of the events was unknown. She wanted to know if this had anything to do with the vaccine and if this could be a side effect. These events did not start happening until after she got the vaccine. Information on the lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 0934899
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/11/2021
Hospital:

Lab Data:

Allergies:

Symptoms: difficulty of breathing; chest pain; nearly passing out/fainting; This is a spontaneous report from a contactable consumer. A 50-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date unknown) via unspecified route of administration on unspecified date at single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter called in behalf of her friend that has been experiencing serious adverse event. The patient experienced difficulty of breathing, chest pain, nearly passing out/fainting on unspecified date. They felt that the vaccination provider did not provide enough support about the adverse event that happened. Follow-up activities are possible, information on the batch number has been requested.

Other Meds:

Current Illness:

ID: 0934900
Sex: F
Age:
State: CO

Vax Date: 01/04/2021
Onset Date: 01/01/2021
Rec V Date: 01/11/2021
Hospital:

Lab Data:

Allergies:

Symptoms: believed it was injected incorrectly because she didn't have pain in her deltoid but she did have all the pain inside her shoulder, like in the bursa; received the first dose 17DEC2020 / received the second dose 4JAN2021; anterior medial shoulder joint/shoulder pain/pain in shoulder after second dose of COVID 19 vaccine; can't actively use shoulder / can't move her arm; weakness in her hand; bone pain; This is a spontaneous report from a contactable healthcare professional (HCP) reporting for herself. A 40-year-old female patient received the first single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EJ1685, expiry date not provided) via an unspecified route of administration in the left arm on 17Dec2020 13:30, and the second dose (lot number EK9231, expiry date not provided)via an unspecified route of administration in the left arm on 04Jan2021 13:30, for COVID-19 immunization. There was no relevant medical history. The patient's concomitant medications were not reported. The patient experienced anterior medial shoulder joint/shoulder pain/pain in shoulder after second dose of the vaccine on 04Jan2021, and couldn't actively use shoulder. She believed it was injected incorrectly because she didn't have pain in her deltoid but she did have all the pain inside her shoulder, like in the bursa, and she couldn't move her arm and felt weakness in her hand. She noticed the pain and all other symptoms immediately when they were injecting it. She told the nurse who said she was tensing up. The events were considered medically significant by the patient. She also reported experiencing bone pain, unable to put in sutures at work. She was taking 600mg Ibuprofen and 1000mg paracetamol (TYLENOL) every 6-8 hours. The events were not resolved. The pain had gotten worse. The other symptoms were persisting.; Sender's Comments: Based on the compatible temporal association, the vaccination with BNT162B2 might play a contributory role in triggering the onset of the events. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0934901
Sex: M
Age: 92
State: OH

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/11/2021
Hospital: Y

Lab Data:

Allergies: NKDA

Symptoms: SEVERE ABDOMINAL PAIN

Other Meds: APAP, amlodipine, metoprolol, ramipril, spironolactone, dutasteride, vitamin B12,

Current Illness:

ID: 0934902
Sex: F
Age:
State: WI

Vax Date: 12/23/2020
Onset Date: 12/23/2020
Rec V Date: 01/11/2021
Hospital:

Lab Data:

Allergies:

Symptoms: tongue not swollen but felt sluggish/tongue felt strange, it was sluggish to swallow; tongue felt strange like hard to swallow/tongue felt strange, it was sluggish to swallow/Her tongue felt strange; tongue felt strange like hard to swallow/tongue felt strange, it was sluggish to swallow/felt hard to swallow; hot flash; flush feeling all over her face/flush all over her face/she felt flush; arm was sore; arm was sore and heavy; drowsiness; pain and redness at injection site; pain and redness at injection site; This is a spontaneous report from a contactable nurse reporting for herself. A 36-year-old female patient received the first single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EL1284, expiry date not provided) on 23Dec2020 09:15 intramuscularly in the left arm for COVID-19 immunisation (reported as preventive). There was no relevant medical history and no concomitant medications. The nurse (patient) received her first dose of the vaccine on 23Dec2020 at the hospital that she worked at. She was kept there for 15 min for monitoring and she felt fine. About 30 minutes post vaccination she got a hot flash, a flush over her face, she does not know if she was red but she felt flush. Her tongue felt strange, nothing swelled that she could tell, it felt hard to swallow, to make the motion to swallow it felt kind of sluggish. She felt weird swallowing which lasted for only a few minutes. She never struggled to breathe. She went back to park in the hospital parking lot since she was not sure if she was experiencing a anaphylactic reaction and then after a few minutes it went away. Her arm was sore and heavy feeling for that day. She had drowsiness for a couple of hours and pain and redness at the injection site for a couple of days that was not bothersome, it was mild. No relevant test. She wanted to know if she should get the second dose of the vaccine due to the symptoms she had after the first dose. The pain and redness at injection site was resolved on an unspecified date in Dec2020, while the other events were resolved on 23Dec2020. The reporting nurse considered the events hot flash, flush all over her face, arm was sore and heavy, drowsiness, pain and redness at injection site were non-serious, while the events "tongue felt strange, it was sluggish to swallow" were serious that she drove back to the hospital (no emergency room/phycian office visit). She considered the events were related to the vaccine.; Sender's Comments: A possible contributory effect of suspect BNT162Bw on the reported events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0934905
Sex: M
Age: 39
State: KY

Vax Date: 12/26/2020
Onset Date: 01/09/2021
Rec V Date: 01/11/2021
Hospital:

Lab Data: NONE

Allergies: NO

Symptoms: DEVELOPED RASH, ITCH AND WARMTH AT INJECTION SITE DAY 14 POST VACCINATION

Other Meds: NO

Current Illness: NO

ID: 0934906
Sex: F
Age:
State: PA

Vax Date: 12/22/2020
Onset Date: 01/04/2021
Rec V Date: 01/11/2021
Hospital: Y

Lab Data: Test Name: cholesterol; Result Unstructured Data: Test Result:elevated cholesterol w/lifestyle changes; Test Name: blood pressure; Result Unstructured Data: Test Result:elevated; Test Name: CT; Result Unstructured Data: Test Result:unknown results; Test Name: LDL; Result Unstructured Data: Test Result:192; Test Name: MRI; Result Unstructured Data: Test Result:unknown results; Test Date: 20210104; Test Name: Nasal Swab; Test Result: Negative ; Test Name: weight; Result Unstructured Data: Test Result:157

Allergies:

Symptoms: experienced symptoms of TIA; Severe aphasia; blurred vision; confusion; short term memory loss; elevated blood pressure; This is a spontaneous report from a contactable Other-HCP(Patient). A 57-year-old female patient received first dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at right arm, on 22Dec2020 08:15 at single dose for COVID-19 immunization. The patient was not pregnant. Medical history included herpes simplex on lips, post menopause, elevated cholesterol w/lifestyle changes. Known allergies reported as no. Concomitant medication included varicella zoster vaccine rge (cho) (SHINGRIX) for immunization. On 04Jan2021 08:30, the patient experienced symptoms of transient ischaemic attack(TIA), severe aphasia, blurred vision, confusion, short term memory loss, elevated blood pressure. The patient admitted to (Hospital name) (still here, hospitalization days reported as 2). Symptoms resolved except very mild aphasia. The patient had very few risk factors for TIA but did have family history of cardiovascular(CV) disease at young age, low density lipoprotein(LDL) was 192. The patient did not have diabetes, HTN, or known heart disease. She did not have severe anxiety. She did not smoke or use any substances. She walked about five miles 4x a week. Weigh reported as 157. Events reported as serious due to hospitalization. The patient had no Covid prior vaccination. Covid(nasal swab) was tested post vaccination on 04Jan2021, Covid test result was Negative. The event resulted in emergency room/department or urgent care. Treatment received for the adverse event included clopidogrel bisulfate(PLAVIX), acetylsalicylic acid (ASPIRIN), statin; potassium, CT, MRI, "telemet". The outcome of the events was recovering. Information on the lot/batch number has been requested.; Sender's Comments: The Company cannot completely exclude the possible causality between the reported symptoms of transient ischaemic attack(TIA), severe aphasia, blurred vision, confusion, short term memory loss, elevated blood pressure and the administration of BNT162B2, based on the reasonable temporal association. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RA, Agency, as appropriate.

Other Meds: SHINGRIX

Current Illness:

ID: 0934907
Sex: M
Age:
State: NM

Vax Date: 12/30/2020
Onset Date:
Rec V Date: 01/11/2021
Hospital:

Lab Data: Test Date: 20210105; Test Name: CT Scan; Result Unstructured Data: Test Result:unknown results

Allergies:

Symptoms: two skin procedures performed in his surgeons office the day before- one on his nose and one on his arm; nose was still slightly bleeding; This is a spontaneous report from a contactable consumer(patient). ?A 72-year-old male patient received first dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 30Dec2020 at single dose for COVID-19 immunization. Medical history included phlebotomy in Sep2020 because his blood was "too thick" and he had no history of a clotting problem until the time of the report. The patient's concomitant medications were not reported. He reported having two skin procedures performed in his surgeons office the day before- one on his nose and one on his arm. The surgeon nicked a vein on his arm and it began bleeding again last night. The arm was addressed in the emergency deportment(ED) and was fine at time of the report. His nose was still slightly bleeding. This morning his blood was drawn for a CT scan and it took a little while to get the bleeding to stop. He had a "phlebotomy" in Sep2020 because his blood was "too thick" and he had no history of a clotting problem until the time of the report. The patient asked if the Covid vaccine act as an anticoagulant. He had not spoken to this HCP yet. He was not on a blood thinner. The reporter considered that the event was non-serious. The outcome of the event arm bleeding/bleeding was recovered, of event "nose was still slightly bleeding" was not recovered. ? Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0934908
Sex: F
Age: 43
State:

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/11/2021
Hospital:

Lab Data:

Allergies: PCN and cephalosporins

Symptoms: Erythema and tenderness with reactive lymph nodes left axillary area The size of erythema is 18x8 cm

Other Meds: no

Current Illness: No

ID: 0934909
Sex: F
Age:
State: CO

Vax Date: 12/30/2020
Onset Date: 12/31/2020
Rec V Date: 01/11/2021
Hospital:

Lab Data: Test Date: 20201231; Test Name: body temperature; Result Unstructured Data: Test Result:101.3

Allergies:

Symptoms: soreness around the injection site; Had severe arm pain; Had a fever on the night of the 31Dec2020 of 101.3; I have painful lymph nodes/the swollen lymph nodes under her right arm, the armpit area had swollen and painful lymph nodes; I have painful lymph nodes/the swollen lymph nodes under her right arm, the armpit area had swollen and painful lymph nodes; had joint pains/knees and hip joint pain; severe fatigue; muscle pain; This is spontaneous report from a contactable nurse (patient). A 59-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), via an unspecified route of administration in right arm on 30Dec2020 14:15 at first single dose (0.3 cc, but really uncertain of dose) for covid-19 immunization. Medical history included COVID virus from Nov2020 to 2020 (The patient was not hospitalized. It was a mild case and lasted about 10 days. she had any positive antibodies at that time. Was off work for about 12 days and was very lucky to have had a very light case with fever, cough, cold, and super fatigue). The patient's concomitant medications were not reported. The patient did not receive any other vaccines at the same time or 4 weeks prior. No problems with vaccinations in past or events. Caller reported she had the first injection of the Pfizer BioNTech COVID-19 vaccine on the 30Dec2020 and having some side effect symptoms and her supervisor recommended for her to report these things, they are not life threatening, obviously, but things were still lingering. Side effect of severe fatigue started on the 31Dec2020 and lasted for 72 hours. It was so severe, now it is mild. The patient reported soreness around the injection site. Had a fever on the night of the 31Dec2020 of 101.3 and had that for 6 hours then it dissipated and was gone. Had never had a fever after injections before. Had severe arm pain that usually goes along with an injection. It started also that night of 31Dec2020. She had rolled over in the middle of the night and it hurt. That lasted for about 48 hours, but it has improved. Had some muscle aches since 31Dec2020 but that had improved and had joint pains since 31Dec2020. What was worrisome was the swollen lymph nodes under her right arm, the armpit area had swollen and painful lymph nodes, since 31Dec2020. The patient was still having that and that is why she was so concerned because shouldn't that have gone away after a week. Had knee and hip joint pain, but that had improved. Again, mentioned she had never had that before with an injection. The patient received vaccine at her workplace. Some of her coworkers got it the same day and no one else has this. Mentioned she did have COVID virus back in Nov2020 and wonders if this correlates with her getting the vaccine. Was not hospitalized or notified she had any positive antibodies at that time. Was off work for about 12 days and was very lucky to have had a very light case with fever, cough, cold, and super fatigue. This is the same way she felt back when she had the virus back in November. The patient was concerned about having these side effects would it be okay for her to get the next injection in 3 weeks. AEs did not require a visit to emergency room and physician office. No further details provided. Outcome of the events Fever was recovered, of event swollen and painful lymph nodes was not recovered, of events knees and hip joint pain, fatigue, muscle pain, severe arm pain was recovering, of event soreness around the injection site was unknown. The reporter considered the events severe fatigue, fever, swollen lymph nodes and pain under right arm, knees and hip joint pain as serious (medically significant). The reporter considered the events severe fatigue, fever, severe arm pain, muscle ache, swollen lymph nodes and pain under right arm, knees and hip joint pain as related to BNT162B2.; Sender's Comments: Based on the compatible temporal association, the vaccination with BNT162B2 might play a contributory role in triggering the onset of the reported events. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0934910
Sex: F
Age:
State: CA

Vax Date: 12/28/2020
Onset Date: 12/28/2020
Rec V Date: 01/11/2021
Hospital:

Lab Data: Test Name: BP; Result Unstructured Data: Test Result:186/90; Test Name: EKG; Result Unstructured Data: Test Result:normal; Test Name: HR; Result Unstructured Data: Test Result:Rapid

Allergies:

Symptoms: chest pressure; tightness /pressure in throat; Face red; BP 186/90; within 2 min. of injection had near syncope that would come in waves every 2-3 minutes; Headache; rapid HR; Chills; mild cough; Dizziness; fatigue; This is a spontaneous report from a non-contactable health care professional nurse, the patient. A 53-years-old non-pregnant female patient (nurse) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EJ1685), in the right arm on 28DEC2020 08:15 as a single dose, for COVID-19 vaccination. Facility where the most recent COVID-19 vaccine was administered was a Hospital. Medical history included asthma and gastroesophageal reflux disease from an unknown date and unknown if ongoing. Known allergies include Tape, Walnuts, and Cat hair. Concomitant medication received within 2 weeks of vaccination included acyclovir [aciclovir] (ACYCLOVIR [ACICLOVIR]), ferrous gluconate, herbal nos, vitamins nos (FLORADIX), lansoprazole (PREVACID), cholecalciferol (VITAMIN D [COLECALCIFEROL]). No other vaccines were given within 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. On 28DEC2020 08:15 within 2 min. of injection had near syncope that would come in waves every 2-3 minutes, face red, chest pressure, tightness /pressure in throat, headache, BP 186/90, rapid HR. The patient Spent 1 hour in ER. Later in day 28Dec2020, continued to have dizziness, chest pressure, chills, headache, fatigue. This continued for 4 days and had mild cough. The adverse events resulted in an emergency room (ER) visit. and Physician Office Visit. Treatment included Xyzal which relieved majority of symptoms. Laboratory test and procedures on 28Dec2020 include Electrocardiogram (EKG) with normal results, Blood Pressure Measurement 186/90 and Heart Rate Rapid. Treatment was given for chest tightness, throat tightness and red face and No treatment was given for chills, cough, dizziness, fatigue, headache, heart rate increase, blood pressure high and near syncope. The clinical outcome of near syncope that would come in waves every 2-3 minutes, face red, chest pressure, tightness /pressure in throat, headache, BP 186/90, rapid HR, dizziness, chest pressure, chills, headache, fatigue, mild cough was recovered. No follow-up attempts are possible. No further information is expected.; Sender's Comments: The Company cannot completely exclude the possible causality between the reported face red, chest pressure, tightness /pressure in throat, blood pressure increased (BP 186/90), near syncope and the administration of BNT162B2, based on the reasonable temporal association. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RA, IEC, as appropriate.

Other Meds: ACYCLOVIR [ACICLOVIR]; FLORADIX; PREVACID; VITAMIN D [COLECALCIFEROL]

Current Illness:

ID: 0934911
Sex: F
Age: 22
State: KS

Vax Date: 01/05/2021
Onset Date: 01/05/2021
Rec V Date: 01/11/2021
Hospital:

Lab Data:

Allergies: N/A

Symptoms: Heart racing and hands swelling, redness/swelling at injection site

Other Meds: acarbose , clonazepam, emgality, proair, propranolol, reglan, sertaline, silver sulfadiazine, topiramate, zofran, zolmitriptan

Current Illness:

ID: 0934912
Sex: F
Age:
State: FL

Vax Date: 12/24/2020
Onset Date: 01/04/2021
Rec V Date: 01/11/2021
Hospital: Y

Lab Data: Test Date: 202101; Test Name: CT scans; Result Unstructured Data: Test Result:unknown result; Test Date: 202101; Test Name: echo; Result Unstructured Data: Test Result:unknown result; Comments: and echo of her heart to make sure there is nothing else; Test Date: 202101; Test Name: doppler; Result Unstructured Data: Test Result:unknown result; Comments: doppler of bilateral legs

Allergies:

Symptoms: DVT; have pain in same site where DVT is; This is a spontaneous report from a contactable consumer. A 28-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EK9291), via an unspecified route of administration in left deltoid on 24Dec2020 10:00 at first single dose for COVID-19 immunization. Medical history was none. There were no concomitant medications. Caller was calling to report a possible adverse reaction to the Pfizer Covid-19 vaccine. The patient was currently at hospital, she was admitted for deep vein thrombosis (DVT) of left iliac vein, the patient had no past history as to why this would happen, that she is only 28 years old. Received the vaccine on 24Dec2020, the following day she did have pain in same site where DVT was. Took ibuprofen for the pain. The patient was admitted yesterday 04Jan2020 for the DVT, they were currently treating her with Lovenox injections and prescribing dose for discharge is Eliquis. CT scans and three shots of Lovenox for it, doing a doppler of bilateral legs and echocardiogram (echo) of her heart to make sure there is nothing else. The AEs require a visit to emergency room. The patient was asking if she can still get the 2nd dose based off the adverse event she experienced. Outcome of DVT was not recovered, of pain was unknown.

Other Meds:

Current Illness:

ID: 0934913
Sex: F
Age:
State: AZ

Vax Date: 12/28/2020
Onset Date: 12/28/2020
Rec V Date: 01/11/2021
Hospital:

Lab Data: Test Name: Body temperature; Result Unstructured Data: Test Result:no fever

Allergies:

Symptoms: Chills; Headache; Coughing; Tiredness; Nasal congested; Feels like her sinus were blocked; Body ache; feeling sick; Sneezing; This is a spontaneous report from a contactable nurse (patient, front line health care worker). A 51-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot#: EH9899) via an unspecified route of administration in the left arm on 28Dec2020 (at 10:30 or 11:00 AM) at single dose for COVID-19 immunization. Medical history included hypertension, diabetes, and stroke, all reported as family history (her parent). There were no concomitant medications. There was no history of all previous immunization with the Pfizer vaccine considered as suspect. There was no additional vaccines administered on same date of the Pfizer suspect. The patient did not have prior vaccinations within 4 weeks. The patient had body ache (reported as medically significant) on 01Jan2021 with outcome of recovering, had been sick for a week/ very ill on 28Dec2020 with outcome of unknown, sneezing on 28Dec2020 with outcome of not recovered, chills on 01Jan2021 with outcome of unknown, headache on 01Jan2021 with outcome of recovering, coughing on 01Jan2021 with outcome of not recovered, tiredness on 01Jan2021 with outcome of unknown, nasal congested on 01Jan2021 with outcome of not recovered, feels like her sinus were blocked on 01Jan2021 with outcome of unknown. Treatment was received for the events. Reported she had a lot of sickness, by evening that day (28Dec2020) she got sneezing and feeling sick. Then the next day was the same, then the third day. She became very ill with chills, body ache, headache, coughing, and tiredness on 01Jan2021 (also reported as 3 days later vaccination). And she had no fever, but stated she had been sick for a week. Added the headache and body ache were a little better but still she felt so congested. Clarified she had nasal congested that feels like her sinus were blocked. She treated herself with acetaminophen, once daily 500 mg by mouth starting 01Jan2021. Added the body ache pain was still on the back of her chest but her legs and arms were better. She used steam inhalation for the congestion. She was not scheduled for the next dose yet, she was just waiting. The patient was wondering if she should do a test for COVID 19. Mentioned she had been healthy all through this year and digging in the COVID 19 all the time but then after the vaccine she got so sick. This was the first day she could get up and did anything. Advised caller to consult her HCP.; Sender's Comments: Based on the information currently provided, the vaccination with BNT162B2 might play a contributory role in triggering the onset of the body ache. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0934914
Sex: F
Age: 41
State: CA

Vax Date: 12/29/2020
Onset Date: 12/29/2020
Rec V Date: 01/11/2021
Hospital:

Lab Data:

Allergies: hydrocodone; gluten

Symptoms: palms of hands started to swell and itch. diaphoretic, then neck started to itch. extended to throat leading to difficulty swallowing

Other Meds: Synthroid, Stratera

Current Illness:

ID: 0934915
Sex: F
Age:
State:

Vax Date: 01/02/2021
Onset Date:
Rec V Date: 01/11/2021
Hospital:

Lab Data: Test Name: TB test; Result Unstructured Data: Test Result:unknown results

Allergies:

Symptoms: TB test; This is a spontaneous report from a contactable consumer. This female consumer (patient) reported that received received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 30Dec2020 at single dose for covid-19 immunisation. Medical history and concomitant medications were unknown. Certified Nursing Assistant got the first dose of the covid vaccine on January 2nd and also she needs to get her TB test. She was told to wait 2weeks between the application and the TB test but the 2 weeks period ends on January 15th and she needs to have the test before that day, so she was wondering if she could get the test done a couple of days early. The outcome of the event was unknown. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0934917
Sex: F
Age: 35
State: MS

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/11/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Extremely severe body aches, sweating, headache, back ache and chills. I also experienced a low grade fever and chest pain. The aches were so intense that standing on my own was almost impossible for 24hours. At the 24 hour mark, my symptoms reduced significantly. Day 2 after the injection was mainly mild body ache and moderate arm pain at the injection site.

Other Meds:

Current Illness:

ID: 0934918
Sex: F
Age:
State: VA

Vax Date: 12/17/2020
Onset Date: 12/17/2020
Rec V Date: 01/11/2021
Hospital:

Lab Data:

Allergies:

Symptoms: 2 week migraine; headache; flushed/Got flushed; persistent extreme dizziness; This is a spontaneous report from a contactable nurse (patient). A 37-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Batch/lot number: EK5730, Intramuscular at single dose on 17Dec2020 19:00 on right arm for precaution as front line health care worker. Medical history included Hemiplegic migraine. Her mother also had migraines. Concomitant medication included ranitidine hydrochloride (ZANTAC) and H1 and H2 blocker. The patient called to report AE of flushed, persistent extreme dizziness, and a headache that has evolved into a 2 week migraine. She has a history of hemiplegic migraines and was taking and h1 and h2 blocker when she received the vaccine. She was calling on guidance whether or not to receive the second vaccine. She was scheduled for second dose on Thursday, but wanted to speak with someone before she got it to see if it was OK. About 15 minutes after receiving the first dose, she got flushed and extremely dizzy. She had a mild headache when she woke up on 18Dec2020 06:00, which then developed into a severe migraine on 22Dec2020 08:00 that she has had for 2 weeks and dizziness continues. She received it at work and there was no prescriber. She called and left a message with Pfizer but has not heard back from anyone yet about this. She would say the flushed and dizziness would be medically serious because she had allergies and had medication on board. She takes daily allergy medication and Zantac and not sure she would not have had a worse reaction if she hadn't had that on board. She took it every night. She had an H1 and H2 blocker on board. Flushed has improved but the dizziness has stayed constant. She had been treated twice for headache and now they have put her on a Prednisone taper. She got it on her right arm so she could work her arm out. On 22Dec2020, she saw a Neurologist for the Migraine. They gave her Toradol 30 mg and Zofran 4mg injection in office. They were given IM. Then, she had another office visit for urgent care on 02Jan2021, and that was for the exacerbation of the migraine. They prescribed 1 liter of fluids and then another Toradol injection, Zofran injection and Decadron injection. The dose of the Toradol was 30 mg, Decadron was 6 mg, and Zofran was 4mg. These were given IV in urgent care. The patient had no prior vaccinations within 4 weeks. The outcome of flushed/Got flushed was resolving. The outcome of other events was not resolved.; Sender's Comments: Based on the compatible temporal association, the vaccination with BNT162B2 might play a contributory role in triggering the onset of the events flushing, dizziness, headache and migraine. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds: ZANTAC

Current Illness:

ID: 0934919
Sex: M
Age:
State:

Vax Date: 01/05/2021
Onset Date: 01/01/2021
Rec V Date: 01/11/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: Heart Rate; Result Unstructured Data: Test Result:Varying; Comments: Varying HR

Allergies:

Symptoms: syncope; diaphoresis; varying HR; blurred vision; This is a spontaneous report from a contactable physician (patient). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 05Jan2021 as single dose for COVID -19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced syncope, diaphoresis, varying HR (heart rate) and blurred vision in Jan2021. The patient underwent lab tests and procedures which included heart rate: varying in Jan2021. Details were as follows: Patient received the vaccine in the morning. He reported diaphoresis, syncope, varying HR, and blurred vision within 10 minutes of receiving the vaccine. He was taken to the emergency room and therapeutic measures were taken as a result of the events; he was given fluids. The patient generally tolerated vaccines and has recovered from the episode. The events, syncope, diaphoresis, varying HR (heart rate) and blurred vision recovered in Jan2021. The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up .; Sender's Comments: Based on the information available, a possible contributory role of the suspect products cannot be excluded for the reported event due to temporal association. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators as appropriate.

Other Meds:

Current Illness:

ID: 0934920
Sex: M
Age:
State: NM

Vax Date: 12/30/2020
Onset Date: 01/04/2021
Rec V Date: 01/11/2021
Hospital:

Lab Data: Test Name: skin biopsies/ skin cancer biopsies; Result Unstructured Data: Test Result:Unknown results; Test Date: 20210104; Test Name: skin biopsies/ skin cancer biopsies; Result Unstructured Data: Test Result:Unknown results; Comments: one of those biopsies was bleeding pretty heavy. It was outpatient and they looked at the incision and put a little clotting tape (or whatever it is) on him and wrapped it up. He hasn't been bleeding.; Test Date: 20210104; Test Name: skin biopsies/ skin cancer biopsies; Result Unstructured Data: Test Result:Unknown results; Comments: The one on his nose is still dripping blood and its coming up on 24 hours now.; Test Date: 20210105; Test Name: lab work/blood drawn; Result Unstructured Data: Test Result:Unknown results; Comments: he didn't clot right away. The blood drawn for the CT scan was drawn early this morning around 7:30 AM.; Test Name: CT Scan; Result Unstructured Data: Test Result:Unknown results

Allergies:

Symptoms: one of those biopsies was bleeding pretty heavy/looked at the incision/The one on his nose is still dripping blood and its coming up on 24 hours now; This is a spontaneous report from a contactable consumer (patient). A 72-year-old male patient received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/lot number: E70124), Intramuscular in arm on 30Dec2020 at single dose for COVID-19 vaccination. Medical history included ongoing blood pressure high and he had been treated for that for a number of years, diabetes from 2009 and ongoing, COPD (chronic obstructive pulmonary disease) issues from 2020 and ongoing and his issues began within the last year, ongoing kidney failure and this started occurring within the last 2 or 3 years, had a urostomy done, had bladder cancer and he had had phlebotomy performed around 3-4 months ago in 2020 and he knew his blood was thick at the time. There were no concomitant medications. The patient received the first vaccine on Wednesday, 30Dec2020. He had noticed something. He had a couple of things happen that basically involved a couple of skin biopsies. He had some lab work drawn for a CT scan, and he didn't clot right away on 05Jan2021. Last night 04Jan2021, he went to the emergency room because one of those biopsies was bleeding pretty heavy. He wanted to know if there is any known connection with the COVID vaccine and anti-clogging. He was going to follow up with the surgeon that did the biopsies. He stated its weird. He had had phlebotomy performed around 3-4 months ago in 2020 and he knew his blood was thick at the time. There had been 2 or 3 incidents where he was not clogging up. He clarified they were skin cancer biopsies, which was something diagnosed prior to receiving the vaccine. It was a follow-up because they didn't get it all the first time and they had to go back in. His skin biopsies were done yesterday, 04Jan2021. He verified when he went to the emergency room last night 04Jan2021 he was not admitted into the hospital. It was outpatient and they looked at the incision and put a little clotting tape (or whatever it is) on him and wrapped it up. He hadn't been bleeding. He knew the doctor nicked a vein. There were 2 biopsies done- one was on his nose. The one on his nose was still dripping blood and its coming up on 24 hours now. The blood drawn for the CT scan was drawn early this morning 05Jan2021 around 7:30 AM. The outcome of the event was not resolved.

Other Meds:

Current Illness: Blood pressure high (Caller states he has been treated for that for a number of years); COPD (Caller states his issues began within the last year); Diabetes; Kidney failure (This started occurring within the last 2 or 3 years . He had a urostomy done. He had bladder cancer)

ID: 0934921
Sex: F
Age: 41
State: WA

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/11/2021
Hospital:

Lab Data: none

Allergies: NKDA, NK Food Allergies

Symptoms: Pateint reports feeling tightness in throat she did take Benadryl, was talking in full complete sentences Denies hives, denies swelling on mouth or SOB SHe called 911 no epi provided

Other Meds: Loestrin 1.5/30 Benadryl PRN

Current Illness: Mild Intermittent Asthma HX of non melanoma skin Cancer

ID: 0934922
Sex: M
Age:
State: TX

Vax Date: 12/16/2020
Onset Date: 12/21/2020
Rec V Date: 01/11/2021
Hospital: Y

Lab Data: Test Date: 20201219; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptoms: Followed by neurological symptoms staring day 4; parasthesias of both upper extremity; progression to muscle weakness of all four extremities/Currently with significant muscle weakness, Left hand weakness leading to dropping of objects and left foot drop; progression to muscle weakness of all four extremities/Currently with significant muscle weakness, Left hand weakness leading to dropping of objects and left foot drop; Flu like symptoms first 3 days; This is a spontaneous report from a contactable physician (patient). A 39-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: ek5730) at left arm, via an unspecified route of administration on 16Dec2020 at single dose for covid-19 immunisation. Medical history included hypertension, diabetes, migraines, Eosinophilic granulomatosis with polyangiitis (EGPA) remission. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not have any allergies to medications, food, or other products. The patient's concomitant medications were not reported. On 21Dec2020, the patient experienced flu like symptoms first 3 days. Followed by neurological symptoms staring day 4, parasthesias of both upper extremity with progression to muscle weakness of all four extremities. Leading to 2 ER visits and hospital admission. Evaluation by internal medicine, neurology and rheumatology. Currently with significant muscle weakness, Left hand weakness leading to dropping of objects and left foot drop. The events resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Disability or permanent damage. The treatment for events included High dose steroid. Covid test included Nasal Swab: negative on 19Dec2020. The outcome of events was not recovered.; Sender's Comments: Based on temporal association, the causal relationship between bnt162b2 and the events influenza like illness, neurological symptom, paraesthesia, muscular weakness and peroneal nerve palsy cannot be excluded. The information available in this report is limited. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0934923
Sex: F
Age: 68
State: IN

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/11/2021
Hospital:

Lab Data:

Allergies: sulfa

Symptoms: Patient received her second dose of shingrix and later developed severe joint pain across many joints. The pain was severe enough that she was unable to walk. She went to the ER for evaluation where she was given pain meds and discharged. The pain continued and she went back to the ER the next day where she was treated again. 3 days after the injection, patient reports joint pain is subsiding and she is now able to walk again.

Other Meds: n/a

Current Illness: n/a

ID: 0934924
Sex: F
Age:
State: OH

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 01/11/2021
Hospital:

Lab Data:

Allergies:

Symptoms: tired; no energy; low back pain; her fingers are hurting; passed out on toilet; Nauseated; hit head on wall, head just hurts; hit head on wall, head just hurts; Chills; she was very cold; could not sleep good; site of vaccine was sore; Muscle pain; Joint pain; This is a spontaneous report from a contactable consumer. A 58-year-old female patient started to receive first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/lot number: EK9231) by injection once to left arm, via an unspecified route of administration on 04Jan2021 12:30 at single dose for covid-19 immunisation. Medical history included thyroid disorder. Concomitant medication included levothyroxine sodium (SYNTHROID) for thyroid disorder; patient started it after she had her son, and her son is 18 years old. The patient had her vaccine yesterday (04Jan2021) at 12:30, and at nighttime, around 22:00, she started having chills, she was very cold, so she went to bed, she could not sleep good, she kept waking up, and the site of vaccine was sore, she had muscle pain, joint pain, she didn't have fever, but she got up late today (05Jan2021), around 11:00, and had breakfast and felt nauseated, so she stopped eating, and she went to the bathroom and passed out on the toilet, when she woke up, she had her nightgown inside the toilet, it was all wet, she felt better, so she stood up and then she woke up again, and was inside the tub, her legs were inside the basin, she was lying down with her back inside the tub, she thinks she hit her head on the wall, and it just hurts, it didn't bleed or nothing. The patient stated she had the paper she was given. Again stated she can not even function. Patient still feels Chills a little bit, not as bad as last night. She is awake now, but she feels very very tired, like she has no energy, she is laying down on couch right now. She kept waking up and noticed this morning, she had low back pain, in the muscles, even her fingers are hurting. Regarding hitting her head on the wall, states she has a terrible headache, not a little pain, she thinks it is because she hurt her head. The patient is supposed to get second vaccination on 25Jan2021. The outcome of events Chills, Joint pain and nauseated was recovering; of events site of vaccine was sore and muscle pain was not recovered; of other events was unknown.

Other Meds: SYNTHROID

Current Illness:

ID: 0934925
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/11/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fainting; This is a spontaneous report from a non-contactable consumer. This consumer reported similar events for 2 patients. This is 2nd of 2 reports. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced fainting on an unspecified date with outcome of unknown. The action taken in response to the event for bnt162b2 was not applicable. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021006219 same reporter/drug/event, different patient

Other Meds:

Current Illness:

ID: 0934926
Sex: F
Age: 53
State: PA

Vax Date: 01/04/2021
Onset Date: 01/08/2021
Rec V Date: 01/11/2021
Hospital:

Lab Data: none

Allergies: none

Symptoms: fever chills diarhea

Other Meds: multivitiams

Current Illness: lupus

ID: 0934927
Sex: F
Age:
State: MI

Vax Date: 01/04/2021
Onset Date: 01/05/2021
Rec V Date: 01/11/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Auditory & visual hallucinations; Auditory & visual hallucinations; tachycardia; extreme panic; confusion; felt like skin was on fire/pulsating; felt like skin was on fire/pulsating; severe pain especially at knees/hips/base of head and neck; severe pain especially at knees/hips/base of head and neck; severe pain especially at knees/hips/base of head and neck; uncontrollable vomiting; bad chills and fever; bad chills and fever; insomnia; felt as if she had been given drugs; This is Spontaneous report from a contactable Other Healthcare Professional reported for herself. This 40-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EK9231), via an unspecified route of administration on 04Jan2021 14:30 at single dose on right arm for COVID-19 immunization. Medical history included COVID prior vaccination and latex allergy. There were no concomitant medications. No other vaccine in four weeks. The patient previously had allergic to diazepam (VALIUM), clonazepam (KLONOPIN), ondansetron (ZOFRAN) and lorazepam (ATIVAN). The patient experienced auditory & visual hallucinations, tachycardia, extreme panic, confusion, felt like skin was on fire/pulsating, severe pain especially at knees/hips/base of head and neck, uncontrollable vomiting, bad chills and fever, insomnia. She felt as if she had been given drugs. All of the events happened on 05Jan2021 01:30 and resulted in Doctor or other healthcare Recovering professional office/clinic visit. No treatment received for the events. No COVID tested post vaccination. The outcome of the events was recovering.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events Auditory hallucinations and Visual hallucinations cannot be totally excluded. The case will be reassessed if additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0934928
Sex: F
Age:
State: MI

Vax Date: 11/08/2020
Onset Date:
Rec V Date: 01/11/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Immunocompromised; This is a spontaneous report from a Pfizer-sponsored program, received via a contactable consumer. A female patient of an unspecified age received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13,Solution for injection in pre-filled syringe, lot number/expiration date unknown) via an unspecified route of administration on 08Nov2020 at a single dose for immunization. Medical history included Crohn's. Concomitant medications included infliximab (INFLECTRA) for Crohn's. The patient was told by her doctor she should get a dose of Pneumovax 23 vaccine in 8 weeks due to her being immunocompromised. However, the pharmacist told her that she should wait for one year. The outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds: INFLECTRA [INFLIXIMAB]

Current Illness:

ID: 0934929
Sex: F
Age:
State: VA

Vax Date: 01/05/2021
Onset Date: 01/05/2021
Rec V Date: 01/11/2021
Hospital:

Lab Data:

Allergies:

Symptoms: rash; All over rash with some itching; This is a spontaneous report from a contactable Nurse reported for self. This 34-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 05Jan 2021 12:50 on right arm at single dose (Lot # EK4176, Expiration Date: Mar2021) for covid-19 immunisation. Medical history was not provided. Concomitant medications were none. Past drug history included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 15Dec2020 16:00 at age of 34 year old at single dose (Lot # EH9899) for covid-19 immunisation. About 30 minutes after being administered (05Jan2021 13:20) that second dose she developed all over rash with some itching. She took Benadryl and Pepcid in response. Today the all over rash with some itching came back at the same persistent level. She wants to know what kind of timeframe she can expect with the continued allergic reaction of all over rash with some itching. She was made to check into the emergency room for observation, but did not have any testing/lab work/investigations done and was not admitted to the hospital. Outcome of the events was not recovered. Reporter seriousness for All over rash with some itching was Medically significant. Drug result was related.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events Rash and Itching cannot be totally excluded. The case will be reassessed if additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0934930
Sex: F
Age: 69
State: FL

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/11/2021
Hospital:

Lab Data: I knew that fever can occur so did not seek medical attention. Just never expected 101.4 temp. May not even qualify as "an adverse event".

Allergies: None

Symptoms: About 18-20 hours after the immunization I felt achy. At 6pm evening of the Jan. 8th I ached all over and temp. of 99.6. Took Tylenol 650mg and went to bed. Up and down most of evening / night, hot and cold, sweating and at 11pm temp. of 100.6 and took Ibuprofen 400mg. Miserable at 3:30am with temp. 101.4 and took Ibuprofen again. Slept well until 9:30am when I awoke with no temp. and feeling great. Temp.s were taken orally. Moderately sore arm. No nausea

Other Meds: Glaucoma eye drops- (Lumigan & Combigan), Mobic used sporadically, Vagifem vaginal suppositories, Metamucil

Current Illness: None

ID: 0934931
Sex: F
Age:
State: AZ

Vax Date: 01/02/2021
Onset Date: 01/03/2021
Rec V Date: 01/11/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Chills with no fever; Cramping in legs; super tired with no energy; Body aches; tiredness/Feeling super tired with no energy; This is a spontaneous report from a contactable consumer. This consumer (patient) reported for self that the 45-year-old female patient who receive first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EH9899), via an unspecified route of administration on Saturday (02Jan2021) at single dose (once by injection in the right arm) for covid-19 immunisation. Medical history included ongoing Hypothyroidism from 2008. Concomitant medications included levothyroxine at 75 ug ongoing from 2008 for Hypothyroidism. Medical Professional and told by her work that she could get it because contact with COVID patients. The consumer calls for information about if the side effects she is experiencing after the administration of the COVID-19 vaccine will last for more days. The consumer reported tiredness and other side effects to DSU. A Consumer calls for information about if it would be appropriate the second dose of the COVID-19 vaccine is not administered considering that she had adverse reactions. Consumer calls for information about if the second dose of the COVID-19 vaccine would cause her more side effects than the first one. Received the vaccine on Saturday, 02Jan2021. The day she got it she did not feel anything at all. She was completely fine. She did not even have pain at the injection site. The next day, on Sunday she started feeling super tired with no energy, had body aches, and cramping in legs from 03Jan2021. She has had these for the past 3 days now. She also had chills with no fever from 03Jan2021 to 05Jan2021. She took Tylenol for the first 2 days, but it did not help her at all. She is feeling a little better today, but not much. Her question is, how long will these side effects last? Tylenol: She says it did help a little bit. She think she would just sleep because she was uncomfortable. The Tylenol just did not make her symptoms go away completely. LOT/Batch: AA46487, EXP: Apr2022 UPC: The consumer says the number under the barcode is: 5187536. Feeling super tired and body aches: Has improved about 20%. She says these are all medically significant as she is not able to do what she was able to do before getting the vaccine. She is super tired with no energy and she is confined to her bed most of the time. The consumer confirms this is her first dose of the COVID Vaccine. She thinks she got the standard dose. Vaccine card does not have the expiration date or NDC written on it. Unknown causality. She said that she could be positive for COVID. She is unsure. The outcome of the event Chills with no fever was recovered. The outcome of the event Cramping in legs was not recovered. The outcome of the other events was recovering.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of reported events cannot be totally excluded. The case will be reassessed if additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness: Hypothyroidism (Patient Medical comments; Verbatim: Hypothyroidism)

ID: 0934932
Sex: F
Age: 37
State: CA

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/11/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Sudden onset dizzyness 5 minutes after immunization.HR Increased 130, decreased to 90 w rest. Transported to medical Clinic for observation

Other Meds:

Current Illness:

ID: 0934933
Sex: M
Age: 57
State: MT

Vax Date: 01/07/2021
Onset Date: 01/11/2021
Rec V Date: 01/11/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Nausea, chills resolved after 24 hrs

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm